Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.416
https://www.valueinhealthjournal.com/article/S1098-3015(13)02321-8/fulltext
Title :
Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02321-8&doi=10.1016/j.jval.2013.08.416
First page :
A395
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
399